A protocol under this subtitle: May authorize: For protocols by a licensed physician and licensed pharmacist, the initiation of drug therapy under written, disease–state specific protocols; The modification, continuation, and discontinuation of drug therapy under written, disease–state specific protocols; The ordering of laboratory tests; and Other patient care management measures related to monitoring or improving the outcomes of drug or device therapy; and May not authorize acts that exceed the scope of practice of the parties to the therapy management contract. A protocol shall prohibit the substitution of a chemically dissimilar drug product by the pharmacist for the product prescribed by the authorized prescriber, unless permitted in the therapy management contract. A protocol that authorizes controlled dangerous substances drug therapy shall require the pharmacist to request relevant data from the Prescription Drug Monitoring Program before initiating or modifying a controlled dangerous substances drug therapy.